[18F]FDG-PET-CT for early monitoring of tumor response: When and why

[18F]FDG-PET-CT for early monitoring of tumor response: When and why (345 views visite)

Storto G, Nicolai E, Salvatore M

Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.

Export to Esporta in BibTeX Export to Esporta in EndNote

Paper type Tipo di articolo: Journal Article,

Impact factor: 1.724, 5-year impact factor Impact factor a 5 anni: 1.952

Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-69449099691&partnerID=40&md5=7bdcec4ce2d1e187972a012bd4045f31

Keywords Parole chiave: Fluorodeoxyglucose F18, Neoplasms, Therapy, Positron Emission Tomography, Cetuximab, Cisplatin, Fluorodeoxyglucose F 18, Fluorouracil, Folinic Acid, Irinotecan, Diagnostic Agent, Brain Tumor, Breast Cancer, Cancer Chemotherapy, Cancer Radiotherapy, Clinical Assessment, Colorectal Cancer, Computer Assisted Tomography, Diagnostic Procedure, Esophagus Cancer, Head And Neck Carcinoma, Human, Lung Non Small Cell Cancer, Monitoring, Outcome Assessment, Quantitative Analysis, Review, Stomach Cancer, Tissue Characterization, Treatment Response, Metabolism, Methodology, Treatment Outcome, Positron-Emission Tomography, X-Ray Computed,

Affiliations Affiliazioni:
*** IBB - CNR ***

IRCCS, CROB, Rionero in Vulture, Potenza, Italy
SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy
Department of Biomorphological and Functional Sciences, University Federico II, Naples, Italy

References Riferimenti:
Therasse, P., Arbuck, S.G., Eisenhauer, E.A., Wanders, J., Kaplan, R.S., Rubinstein, L., New guidelines to evaluate the response to treatment in solid tumors (2000) J Natl Cancer Inst, 92, pp. 205-216. , European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canad

Eisenhauer, E.A., Therasse, P., Bogaerts, J., Schwartz, L.H., Sargent, D., Ford, R., New response evaluation criteria in solid tumours: Revised RECIST guideline (2009) Eur J Cancer, 45, pp. 228-247. , version 1.1

Fleming, T.R., Prentice, R.L., Pepe, M.S., Gidden, D., Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research (1994) Stat Med, 13, pp. 955-968

Junker, K., Langner, K., Klinke, F., Bosse, U., Thomas, M., Grading of tumor regression in non-small cell lung cancer: Morphology and prognosis (2001) Chest, 120, pp. 1584-1591

Vecchio, F.M., Valentini, V., Minsky, B.D., Padula, G.D., Venkatraman, E.S., Balducci, M., The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer (2005) Int J Radiat Oncol Biol Phys, 62, pp. 752-760

Mandard, A.M., Dalibard, F., Mandard, J.C., Marnay, J., Henry-Amar, M., Petiot, J.F., Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations (1994) Cancer, 73, pp. 2680-2686

Heinrich, S., Schäfer, M., Weber, A., Hany, T.F., Bhure, U., Pestalozzi, B.C., Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: Results of a prospective phase II trial (2008) Ann Surg, 248, pp. 1014-1022

Bacci, G., Ferrari, S., Bertoni, F., Picci, P., Bacchini, P., Longhi, A., Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy (2001) Clin Orthop Relat Res, 386, pp. 186-196

Rajan, R., Poniecka, A., Smith, T.L., Yang, Y., Frye, D., Pusztai, L., Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response (2004) Cancer, 100, pp. 1365-1373

Horiuchi, C., Taguchi, T., Yoshida, T., Nishimura, G., Kawakami, M., Tanigaki, Y., Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography (2008) Auris Nasus Larynx, 35, pp. 103-108

Brücher, B.L., Weber, W., Bauer, M., Fink, U., Avril, N., Stein, H.J., Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography (2001) Ann Surg, 233, pp. 300-309

Mac Manus, M.P., Hicks, R.J., Matthews, J.P., McKenzie, A., Rischin, D., Salminen, E.K., Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer (2003) J Clin Oncol, 21, pp. 1285-1292

Swisher, S.G., Maish, M., Erasmus, J.J., Correa, A.M., Ajani, J.A., Bresalier, R., Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer (2004) Ann Thorac Surg, 78, pp. 1152-1160

Ryu, J.S., Choi, N.C., Fischman, A.J., Lynch, T.J., Mathisen, D.J., FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: Correlation with histopathology (2002) Lung Cancer, 35, pp. 179-187

Bassa, P., Edmund Kim, E., Inoue, T., Wong, F.C.L., Korkmaz, M., Yang, D.J., Wong, W.-H., Podoloff, D.A., Evaluation of Preoperative Chemotherapy Using PET with Fluorine-18-Fluorodeoxyglucose in Breast Cancer (1996) Journal of Nuclear Medicine, 37 (6), pp. 931-938

Burcombe, R.J., Makris, A., Pittam, M., Lowe, J., Emmott, J., Wong, W.L., Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography (2002) Eur J Cancer, 38, pp. 375-379

Kim, S.J., Kim, S.K., Lee, E.S., Ro, J., Kang, S., Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy (2004) Ann Oncol, 15, pp. 1352-1357

Wahl, R.L., Zasadny, K., Helvie, M., Hutchins, G.D., Weber, B., Cody, R., Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation (1993) Journal of Clinical Oncology, 11 (11), pp. 2101-2111

Grigsby, P.W., Siegel, B.A., Dehdashti, F., Rader, J., Zoberi, I., Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome (2004) J Clin Oncol, 22, pp. 2167-2171

(1979) WHO Handbook for Reporting Results of Cancer Treatment, , Geneva (Switzerland): World Health Organization Offset Publication No. 48

Miller, A.B., Hogestraeten, B., Staquet, M., Winkler, A., Reporting results of cancer treatment (1981) Cancer, 47, pp. 207-214

James, K., Eisenhauer, E., Christian, M., Terenziani, M., Vena, D., Muldal, A., Therasse, P., Measuring response in solid tumors: Unidimensional versus bidimensional measurement (1999) Journal of the National Cancer Institute, 91 (6), pp. 523-528

Graf, W., Pahlman, L., Bergstrom, R., Glimelius, B., The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer (1994) British Journal of Cancer, 70 (3), pp. 559-563

Lavin, P., Mittelman, A., Douglass, H., Engström, P., Klaassen, D., Survival and response to chemotherapy for advanced colorectal adenocarcinoma (1980) Cancer, 46, pp. 1536-1543

Anderson, J.R., Cain, K.C., Gelber, R.D., Analysis of survival by tumor response (1983) J Clin Oncol, 1, pp. 710-719

Sörenson, S., Glimelius, B., Nygren, P., A systematic overview of chemotherapy effects in non-small cell lung cancer (2001) Acta Oncol, 40, pp. 327-339. , SBU-group. Swedish Council of Technology Assessment in Health Care

Gonzalez-Angulo, A.M., Morales-Vasquez, F., Hortobagyi, G.N., Overview of resistance to systemic therapy in patients with breast cancer (2007) Adv Exp Med Biol, 608, pp. 1-22

Ragnhammar, P., Hafström, L., Nygren, P., Glimelius, B., A systematic overview of chemotherapy effects in colorectal cancer (2001) Acta Oncol, 40, pp. 282-308. , SBU-group. Swedish Council of Technology Assessment in Health Care

Weiss, G.B., Bunce III, H., Hokanson, J.A., Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trials (1983) Controlled Clinical Trials, 4 (1), pp. 43-52

Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A.A., Measurement of Clinical and Subclinical Tumor Response Using [18F]-fluorodeoxyglucose and Positron Emission Tomography: Review and 1999 EORTC Recommendations (1999) Eur J Cancer, 35, pp. 1773-1782. , on behalf of the European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

Zasadny, K.R., Wahl, R.L., Standardised uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose:Variations with body weight and a method for correction (1993) Radiology, 189, pp. 847-850

Kim, C.K., Gupta, N.C., Dependency of standardised uptake values of fluorine-18 fluorodeoxyglucose on body size: Comparison of body surface area correction and lean body mass correction (1996) Nucl Med Commun, 17, pp. 890-894

Lammertsma, A.A., Brooks, D.J., Frackowiak, R.S.J., Beaney, R.P., Herold, S., Heather, J.D., Measurement of glucose utilisation with [18F]-fluoro-2-deoxy-d-glucose:A comparison of different analytical methods (1987) J Cereb Blood Flow Metab, 7, pp. 161-172

Sugawara, Y., Zasadny, K.R., Grossman, H.B., Francis, I.R., Clarke, M.F., Wahl, R.L., Germ cell tumor: Differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling (1999) Radiology, 211 (1), pp. 249-256

Brock, C.S., Young, H., Reilly, S.M., Matthews, J., Osman, S., Evans, H., Newlands, E.S., Price, P.M., Early evaluation of tumour metabolic response using [18F] fluorodeoxyglucose and positron emission tomography: A pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas (2000) British Journal of Cancer, 82 (3), pp. 608-615

Charnley, N., West, C.M., Barnett, C.M., Brock, C., Bydder, G.M., Glaser, M., Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy (2006) Int J Radiat Oncol Biol Phys, 66, pp. 331-338

Brun, E., Kjellen, E., Tennvall, J., Ohlsson, T., Sandell, A., Perfekt, R., FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma (HNSCC) (2002) Head Neck, 24, pp. 127-135

Schwarz, J.D., Bader, M., Jenicke, L., Hemminger, G., Janicke, F., Avril, N., Early prediction of response to chemotherapy in metastatic breast cancer using sequential18F-FDG PET (2005) Journal of Nuclear Medicine, 46 (7), pp. 1144-1150

Hoekstra, C.J., Stroobants, S.G., Smit, E.F., Vansteenkiste, J., Van Tinteren, H., Postmus, P.E., Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy- D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer (2005) J Clin Oncol, 23, pp. 8362-8370

Wieder, H.A., Brücher, B.L., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment (2004) J Clin Oncol, 22, pp. 900-908

Ott, K., Herrmann, K., Lordick, F., Wieder, H., Weber, W.A., Becker, K., Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: Long-term results of a prospective study (2008) Clin Cancer Res, 14, pp. 2012-2018

Avril, N., Sassen, S., Schmalfeldt, B., Naehrig, J., Rutke, S., Weber, W.A., Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer (2005) J Clin Oncol, 20 (23), pp. 7445-7453

Wong, T.Z., Van Der Westhuizen, G.J., Coleman, R.E., Positron emission tomography imaging of brain tumors (2002) Neuroimaging Clin N Am, 12, pp. 615-626

Olivero, W.C., Dulebohn, S.C., Lister, J.R., The use of PET in evaluating patients with primary brain tumors: Is it useful? (1995) J Neurol Neurosurg Psychiatry, 58, pp. 250-252

Ricci, P.E., Karis, J.P., Heiserman, J.E., Fram, E.K., Bice, A.N., Drayer, B.P., Differentiating recurrent tumor from radiation necrosis: Time for reevaluation of positron emission tomography? (1998) AJNR, 19, pp. 407-413

De Witte, O., Hildebrand, J., Luxen, A., Goldman, S., Acute effect of carmustine on glucose metabolism in brain and glioblastoma (1994) Cancer, 74, pp. 2836-2842

O'Reilly, S.M., Newlands, E.S., Harte, R.J.A., Early changes in tumor glucose metabolism may predict and quantify response of gliomas to chemotherapy: A phase II study using temozolomide (1995) Proc Am Soc Clin Oncol, 14, p. 499

Holthoff, V.A., Herholz, K., Berthold, F., Widemann, B., Schröder, R., Neubauer, I., In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment (1993) Cancer, 72, pp. 1394-1403

Reisser, C., Haberkorn, U., Dimitrakopoulou-Strauss, A., Seifert, E., Strauss, L.G., Chemotherapeutic management of head and neck malignancies with positron emission tomography (1995) Arch Otolaryngol Head Neck Surg, 121, pp. 272-276

Berlangieri, S.U., Brizel, D.M., Scher, R.L., Schifter, T., Hawk, T.C., Hamblen, S., Coleman, R.E., Hoffman, J.M., Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy (1994) Head and Neck, 16 (4), pp. 340-346

Brun, E., Ohlsson, T., Erlandsson, K., Kjellen, E., Sandell, A., Tennvall, J., Wennerberg, J., Strand, S.-E., Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET (1997) Acta Oncologica, 36 (7), pp. 741-747

Haberkorn, U., Strauss, L.G., Dimitrakopoulou, A., Seiffert, E., Oberdorfer, F., Ziegler, S., Reisser, C., Van Kaick, G., Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy (1993) Journal of Nuclear Medicine, 34 (1), pp. 12-17

Dalsaso, T.A., Lowe, V.J., Dunphy, F.R., Martin, D.S., Boyd, J.H., Stack, B.C., FDG PET and CT in evaluation of chemotherapy in advanced head and neck cancer (2000) Clin Positron Imaging, 3, pp. 1-5

Greven, K.M., Williams, D.W., Keyes Jr., J.W., McGuirt, W.F., Watson Jr., N.E., Randall, M.E., Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation (1994) Cancer, 74, pp. 1355-1359

Rege, S., Safa, A.A., Chaiken, L., Hoh, C., Juillard, G., Withers, H.R., Positron emission tomography: An independent indicator of radiocurability in head and neck carcinomas (2000) Am J Clin Oncol, 23, pp. 164-169

Higashi, K., Ueda, Y., Yagishita, M., Arisaka, Y., Sakurai, A., Oguchi, M., Seki, H., Yamamoto, I., FDG PET measurement of the proliferative potential of non-small cell lung cancer (2000) Journal of Nuclear Medicine, 41 (1), pp. 85-92

Kunkel, M., Forster, G.J., Reichert, T.E., Kutzner, J., Benz, P., Bartenstein, P., Radiation response non-invasively imaged by [18F]FDG PET predicts local tumor control and survival in advanced oral squamous cell carcinoma (2003) Oral Oncol, 39, pp. 170-177

Smith, I.C., Welch, A.E., Hutcheon, A.W., Miller, I.D., Payne, S., Chilcott, F., Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy (2000) J Clin Onco, 18, pp. 1676-1688

Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer (2000) J Clin Oncol, 18, pp. 1689-1695

Mankoff, D.A., Dunnwald, L.K., Gralow, J.R., Ellis, G.K., Schubert, E.K., Tseng, J., Lawton, T.J., Livingston, R.B., Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy (2003) Journal of Nuclear Medicine, 44 (11), pp. 1806-1814

Gennari, A., Donati, S., Salvadori, B., Giorgetti, A., Salvadori, P.A., Sorace, O., Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients (2000) Clin Breast Cancer, 1, pp. 156-161

Weber, W.A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use (2003) J Clin Oncol, 21, pp. 2651-2657

Eschmann, S.M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer (2007) Eur J Nucl Med Mol Imaging, 34, pp. 463-471

De Geus-Oei, L.F., Van Der Heijden, H.F., Visser, E.P., Hermsen, R., Van Hoorn, B.A., Timmer-Bonte, J.N., Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer (2007) J Nucl Med, 48, pp. 1592-1598

Nahmias, C., Hanna, W.T., Wahl, L.M., Long, M.J., Hubner, K.F., Townsend, D.W., Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT (2007) J Nucl Med, 48, pp. 744-751

Couper, G.W., McAteer, D., Wallis, F., Norton, M., Welch, A., Nicolson, M., Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer (1998) Br J Surg, 85, pp. 1403-1406

Weber, W.A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N.E., Meisetschlager, G., Fink, U., Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging (2001) Journal of Clinical Oncology, 19 (12), pp. 3058-3065

Nakamura, R., Obara, T., Katsuragawa, S., Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after RT (2002) Radiat Med, 20, pp. 181-186

Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.J., Busch, R., Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial (2003) J Clin Oncol, 21, pp. 4604-4610

Di Fabio, F., Pinto, C., Rojas Llimpe, F.L., Fanti, S., Castellucci, P., Longobardi, C., The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab (2007) Gastric Cancer, 10, pp. 221-227

Shinto, A., Nair, N., Dutt, A., Baghel, N.S., Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib (2008) Clin Nucl Med, 33, pp. 486-487

Guillem, J.G., Puig-La Jr., C.J., Akhurst, T., Tickoo, S., Ruo, L., Minsky, B.D., Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography (2000) Dis Colon Rectum, 43, pp. 18-24

Amthauer, H., Denecke, T., Rau, B., Hildebrandt, B., Hunerbein, M., Ruf, J., Schneider, U., Wust, P., Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology (2004) European Journal of Nuclear Medicine and Molecular Imaging, 31 (6), pp. 811-819

Calvo, F.A., Domper, M., Matute, R., Martínez-Lázaro, R., Arranz, J.A., Desco, M., 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation (2004) Int J Radiat Oncol Biol Phys, 58, pp. 528-535

Langenhoff, B.S., Oyen, W.J., Jager, G.J., Strijk, S.P., Wobbes, T., Corstens, F.H., Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: A prospective study (2002) J Clin Oncol, 20, pp. 4453-4458

Joosten, J., Jager, G., Oyen, W., Wobbes, T., Ruers, T., Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases (2005) Eur J Surg Oncol, 31, pp. 1152-1159

Lubezky, N., Metser, U., Geva, R., Nakache, R., Shmueli, E., Klausner, J.M., The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: Comparison with operative and pathological findings (2007) J Gastrointest Surg, 11, pp. 472-478

Findlay, M., Young, H., Cunningham, D., Iveson, A., Cronin, B., Hickish, T., Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil (1996) J Clin Oncol, 14, pp. 700-708

Bender, H., Bangard, N., Metten, N., Bangard, M., Mezger, J., Schomburg, A., Biersack, H.-J., Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer (1999) Hybridoma, 18 (1), pp. 87-91

Rigo, P., Paulus, P., Kaschten, B.J., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., Foidart-Willems, J., Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose (1996) European Journal of Nuclear Medicine, 23 (12), pp. 1641-1674

Kasper, B., Dietrich, S., Dimitrakopoulou-Strauss, A., Strauss, L.G., Haberkorn, U., Ho, A.D., Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography (2008) Onkologie, 31, pp. 107-112

Bouchelouche, K., Oehr, P., Recent developments in urologic oncology: Positron emission tomography molecular imaging (2008) Curr Opin Oncol, 20, pp. 321-326

Avril, N.E., Weber, W.A., Monitoring response to treatment in patients utilizing PET (2005) Radiol Clin North Am, 43, pp. 189-204

Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F] FDG) after first-line chemotherapy in non- Hodgkin's lymphoma: Is [18F]FDGPET a valid alternative to conventional diagnosis methods? (2001) J Clin Oncol, 19, pp. 414-419

Kostakoglu, L., Coleman, M., Leonard, J.P., Kuji, I., Zoe, H., Goldsmith, S.J., PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease (2002) J Nucl Med, 43, pp. 1018-1027

Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., New response evaluation criteria in solid tumours: Revised RECIST guideline (2009) Eur J Cancer, 45, pp. 228-247. , version 1. 1

Fleming, T. R., Prentice, R. L., Pepe, M. S., Gidden, D., Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research (1994) Stat Med, 13, pp. 955-968

Vecchio, F. M., Valentini, V., Minsky, B. D., Padula, G. D., Venkatraman, E. S., Balducci, M., The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer (2005) Int J Radiat Oncol Biol Phys, 62, pp. 752-760

Mandard, A. M., Dalibard, F., Mandard, J. C., Marnay, J., Henry-Amar, M., Petiot, J. F., Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations (1994) Cancer, 73, pp. 2680-2686

Heinrich, S., Sch fer, M., Weber, A., Hany, T. F., Bhure, U., Pestalozzi, B. C., Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: Results of a prospective phase II trial (2008) Ann Surg, 248, pp. 1014-1022

Br cher, B. L., Weber, W., Bauer, M., Fink, U., Avril, N., Stein, H. J., Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography (2001) Ann Surg, 233, pp. 300-309

Mac Manus, M. P., Hicks, R. J., Matthews, J. P., McKenzie, A., Rischin, D., Salminen, E. K., Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer (2003) J Clin Oncol, 21, pp. 1285-1292

Swisher, S. G., Maish, M., Erasmus, J. J., Correa, A. M., Ajani, J. A., Bresalier, R., Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer (2004) Ann Thorac Surg, 78, pp. 1152-1160

Ryu, J. S., Choi, N. C., Fischman, A. J., Lynch, T. J., Mathisen, D. J., FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: Correlation with histopathology (2002) Lung Cancer, 35, pp. 179-187

Burcombe, R. J., Makris, A., Pittam, M., Lowe, J., Emmott, J., Wong, W. L., Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F] -fluorodeoxyglucose positron emission tomography (2002) Eur J Cancer, 38, pp. 375-379

Kim, S. J., Kim, S. K., Lee, E. S., Ro, J., Kang, S., Predictive value of [18F] FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy (2004) Ann Oncol, 15, pp. 1352-1357

Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., Cody, R., Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation (1993) Journal of Clinical Oncology, 11 (11), pp. 2101-2111

Grigsby, P. W., Siegel, B. A., Dehdashti, F., Rader, J., Zoberi, I., Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome (2004) J Clin Oncol, 22, pp. 2167-2171

(1979) WHO Handbook for Reporting Results of Cancer Treatment, , Geneva (Switzerland): World Health Organization Offset Publication No. 48

Miller, A. B., Hogestraeten, B., Staquet, M., Winkler, A., Reporting results of cancer treatment (1981) Cancer, 47, pp. 207-214

Anderson, J. R., Cain, K. C., Gelber, R. D., Analysis of survival by tumor response (1983) J Clin Oncol, 1, pp. 710-719

S renson, S., Glimelius, B., Nygren, P., A systematic overview of chemotherapy effects in non-small cell lung cancer (2001) Acta Oncol, 40, pp. 327-339. , SBU-group. Swedish Council of Technology Assessment in Health Care

Weiss, G. B., Bunce III, H., Hokanson, J. A., Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trials (1983) Controlled Clinical Trials, 4 (1), pp. 43-52

Zasadny, K. R., Wahl, R. L., Standardised uptake values of normal tissues at PET with 2- [fluorine-18] -fluoro-2-deoxy-d-glucose: Variations with body weight and a method for correction (1993) Radiology, 189, pp. 847-850

Kim, C. K., Gupta, N. C., Dependency of standardised uptake values of fluorine-18 fluorodeoxyglucose on body size: Comparison of body surface area correction and lean body mass correction (1996) Nucl Med Commun, 17, pp. 890-894

Lammertsma, A. A., Brooks, D. J., Frackowiak, R. S. J., Beaney, R. P., Herold, S., Heather, J. D., Measurement of glucose utilisation with [18F] -fluoro-2-deoxy-d-glucose: A comparison of different analytical methods (1987) J Cereb Blood Flow Metab, 7, pp. 161-172

Brock, C. S., Young, H., Reilly, S. M., Matthews, J., Osman, S., Evans, H., Newlands, E. S., Price, P. M., Early evaluation of tumour metabolic response using [18F] fluorodeoxyglucose and positron emission tomography: A pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas (2000) British Journal of Cancer, 82 (3), pp. 608-615

Schwarz, J. D., Bader, M., Jenicke, L., Hemminger, G., Janicke, F., Avril, N., Early prediction of response to chemotherapy in metastatic breast cancer using sequential18F-FDG PET (2005) Journal of Nuclear Medicine, 46 (7), pp. 1144-1150

Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., Van Tinteren, H., Postmus, P. E., Prognostic relevance of response evaluation using [18F] -2-fluoro-2-deoxy- D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer (2005) J Clin Oncol, 23, pp. 8362-8370

Wieder, H. A., Br cher, B. L., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment (2004) J Clin Oncol, 22, pp. 900-908

Wong, T. Z., Van Der Westhuizen, G. J., Coleman, R. E., Positron emission tomography imaging of brain tumors (2002) Neuroimaging Clin N Am, 12, pp. 615-626

Olivero, W. C., Dulebohn, S. C., Lister, J. R., The use of PET in evaluating patients with primary brain tumors: Is it useful? (1995) J Neurol Neurosurg Psychiatry, 58, pp. 250-252

Ricci, P. E., Karis, J. P., Heiserman, J. E., Fram, E. K., Bice, A. N., Drayer, B. P., Differentiating recurrent tumor from radiation necrosis: Time for reevaluation of positron emission tomography? (1998) AJNR, 19, pp. 407-413

O'Reilly, S. M., Newlands, E. S., Harte, R. J. A., Early changes in tumor glucose metabolism may predict and quantify response of gliomas to chemotherapy: A phase II study using temozolomide (1995) Proc Am Soc Clin Oncol, 14, p. 499

Holthoff, V. A., Herholz, K., Berthold, F., Widemann, B., Schr der, R., Neubauer, I., In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment (1993) Cancer, 72, pp. 1394-1403

Berlangieri, S. U., Brizel, D. M., Scher, R. L., Schifter, T., Hawk, T. C., Hamblen, S., Coleman, R. E., Hoffman, J. M., Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy (1994) Head and Neck, 16 (4), pp. 340-346

Dalsaso, T. A., Lowe, V. J., Dunphy, F. R., Martin, D. S., Boyd, J. H., Stack, B. C., FDG PET and CT in evaluation of chemotherapy in advanced head and neck cancer (2000) Clin Positron Imaging, 3, pp. 1-5

Greven, K. M., Williams, D. W., Keyes Jr., J. W., McGuirt, W. F., Watson Jr., N. E., Randall, M. E., Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation (1994) Cancer, 74, pp. 1355-1359

Rege, S., Safa, A. A., Chaiken, L., Hoh, C., Juillard, G., Withers, H. R., Positron emission tomography: An independent indicator of radiocurability in head and neck carcinomas (2000) Am J Clin Oncol, 23, pp. 164-169

Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Positron emission tomography using [(18) F] -fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy (2000) J Clin Onco, 18, pp. 1676-1688

Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Schubert, E. K., Tseng, J., Lawton, T. J., Livingston, R. B., Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy (2003) Journal of Nuclear Medicine, 44 (11), pp. 1806-1814

Weber, W. A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use (2003) J Clin Oncol, 21, pp. 2651-2657

Eschmann, S. M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer (2007) Eur J Nucl Med Mol Imaging, 34, pp. 463-471

De Geus-Oei, L. F., Van Der Heijden, H. F., Visser, E. P., Hermsen, R., Van Hoorn, B. A., Timmer-Bonte, J. N., Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer (2007) J Nucl Med, 48, pp. 1592-1598

Couper, G. W., McAteer, D., Wallis, F., Norton, M., Welch, A., Nicolson, M., Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer (1998) Br J Surg, 85, pp. 1403-1406

Weber, W. A., Ott, K., Becker, K., Dittler, H. -J., Helmberger, H., Avril, N. E., Meisetschlager, G., Fink, U., Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging (2001) Journal of Clinical Oncology, 19 (12), pp. 3058-3065

Guillem, J. G., Puig-La Jr., C. J., Akhurst, T., Tickoo, S., Ruo, L., Minsky, B. D., Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography (2000) Dis Colon Rectum, 43, pp. 18-24

Calvo, F. A., Domper, M., Matute, R., Mart nez-L zaro, R., Arranz, J. A., Desco, M., 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation (2004) Int J Radiat Oncol Biol Phys, 58, pp. 528-535

Langenhoff, B. S., Oyen, W. J., Jager, G. J., Strijk, S. P., Wobbes, T., Corstens, F. H., Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: A prospective study (2002) J Clin Oncol, 20, pp. 4453-4458

Avril, N. E., Weber, W. A., Monitoring response to treatment in patients utilizing PET (2005) Radiol Clin North Am, 43, pp. 189-204

[18F]FDG-PET-CT for early monitoring of tumor response: When and why

18F-fluorodeoxyglucose positron emission tomography ([ 18F]FDG PET) has been recognized as a suitable tool in tumor response assessment of patients complaining with solid tumors who have undergone chemo- and radiotherapy. It offers the advantage of functional tissue characterization, which is independent from morphologic criteria allowing to differentiate disease relapse from therapy-induced fibrosis. At present, there is a growing body of evidence that PET semi-quantitative assessment of treatment-induced changes in tumor [18F]FDG avidity may predict early tumor response and patient outcome. Patient management might be changed. For instance, in non responder patients this novel diagnostic approach would hamper useless "wait and watch" attitude in implementing further options or identifying those needing additional therapeutic strategies. On the other hand, for those patients revealing promptly a favourable metabolic response a cost-sparing approach could be implemented avoiding expensive diagnostic procedures during the follow-up as well as the risk of over-treating. In any case, since even a partial metabolic response may be an indication for continuing therapy, the advantage of metabolic assessment over conventional procedures may be clinically relevant. Although a morphological assessment has been considered for long time the standard for detecting therapy response, limitations of conventional computed tomography-based evaluation in solid tumors are well-known. PET provides an independent means of assessing malignancy. However, no consensus has been achieved until now regarding the optimal timing in performing PET during or at completion of treatment.

[18F]FDG-PET-CT for early monitoring of tumor response: When and why

Your query Interrogazione effettuata: [atitle, adesc, keywords] "Fluorodeoxyglucose F18" OR [atitle, adesc, keywords] "Positron Emission Tomography" OR [atitle, adesc, keywords] "Fluorodeoxyglucose F 18" OR [atitle, adesc, keywords] "Fluorouracil" OR [atitle, adesc, keywords] "Folinic Acid"

Your query Interrogazione effettuata: [atitle, adesc, keywords] "Fluorodeoxyglucose F18" OR [atitle, adesc, keywords] "Positron Emission Tomography" OR [atitle, adesc, keywords] "Fluorodeoxyglucose F 18" OR [atitle, adesc, keywords] "Fluorouracil" OR [atitle, adesc, keywords] "Folinic Acid"

▼ High-resolution positron emission tomography of the ischaemic mouse heart Tomografia ad emissione di positroni (PET) ad alta risoluzione in modello murino di ischemia miocardica

Gargiulo Sara

▼ Comparison of noninvasive cardiac imaging modalities in patients with myocardial infarction

Cuocolo Alberto

[18F]FDG-PET-CT for early monitoring of tumor response: When and why

Your query Interrogazione effettuata: Fluorodeoxyglucose F18, Neoplasms, Therapy, Positron Emission Tomography, Cetuximab, Cisplatin, Fluorodeoxyglucose F 18, Fluorouracil, Folinic Acid, Irinotecan, Diagnostic Agent, Brain Tumor, Breast Cancer, Cancer Chemotherapy, Cancer Radiotherapy, Clinical Assessment, Colorectal Cancer, Computer Assisted Tomography, Diagnostic Procedure, Esophagus Cancer, Head And Neck Carcinoma, Human, Lung Non Small Cell Cancer, Monitoring, Outcome Assessment, Quantitative Analysis, Review, Stomach Cancer, Tissue Characterization, Treatment Response, Metabolism, Methodology, Treatment Outcome, Positron-Emission Tomography, X-Ray Computed, [btitle, keywords] "Fluorodeoxyglucose F18" [btitle, keywords] "Positron Emission Tomography" [btitle, keywords] "Fluorodeoxyglucose F 18" [btitle, keywords] "Fluorouracil" [btitle, keywords] "Folinic Acid"

Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote

Guzzardi MA, La Rosa F, Campani D, Cacciato Insilla A, De Sena V, Panetta D, Brunetto MR, Bonino F, Collado MC, Iozzo P
* Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet (0 visite)
Nutrients (ISSN: 2072-6643linking), 2021 Sep 28; 13 (10 ): N/D-N/D.
Impact Factor:
Dettagli    Esporta in BibTeX    Esporta in EndNote

Larobina M, Megna R, Solla R
* Comparison of three freeware software packages for (18)F-FDG PET texture feature calculation (50 visite)
Jpn J Radiol (ISSN: 1867-1071linking), 2021 Jul; 39(7): 710-719.
Impact Factor: 1.439
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Nardelli A, Calice G, Guarini A, Guglielmi G, Storto G
* F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study (8 visite)
Eur J Radiol (ISSN: 0720-048xlinking), 2021 Mar; 136: 109564-109564.
Impact Factor: 3.528
Dettagli    Esporta in BibTeX    Esporta in EndNote

Coda AR, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G, Annunziato L, Salvatore M, Brunetti A, De Berardinis P, Quarantelli M, Palma G, Pappata S
* In vivo imaging of CNS microglial activation/macrophage infiltration with combined [(18)F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis (115 visite) (PDF 42 visite)
Eur J Nucl Med (ISSN: 1619-7070linking, 1619-7089electronic, 1619-7070print), 2021 Jan; 48(1): 40-52.
Impact Factor: 7.18
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore B, Fonti R, De Renzo A, Pellegrino S, Ferrara IL, Mainolfi CG, Marano L, Selleri C, Pane F, Del Vecchio S, Pace L
* 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis (156 visite)
Q J Nucl Med Mol Im (ISSN: 1827-1936electronic, 1824-4785linking), 2020 Jun; 64(2): 219-225.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Pellegrino S, Catalano L, Pane F, Del Vecchio S, Pace L
* Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma (103 visite)
Ann Hematol (ISSN: 0939-5555linking), 2020 Jan; 99(1): 127-135.
Impact Factor: 2.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (123 visite)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH, Bottlaender M, Brooks D, Carroll MA, Chalon S, Gee A, Gerhard A, Halldin C, Herholz K, Herth MM, Hinz R, Knudsen GM, Kuhnast B, López-picón F, Moresco RM, Pappata S, Rinne JO, Rodriguez-vieitez E, Santiago-ribeiro MJ, Turkheimer FE, Van Laere K, Varrone A, Vercouillie J, Winkeler A
* A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies (192 visite)
Alzheimers Dement (ISSN: 1552-5260linking), 2019 Jun 20; N/D: N/D-N/D.
Impact Factor: 14.43
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perani D, Iaccarino L, Jacobs AH, Lammertsma AA, Nordberg A, Windhorst AD, Gerhard A, Winkeler A, Jacobs AH, Gee A, Kuhnast B, Halldin C, Perani D, Brooks D, Rodriguez-vieitez E, Turkheimer FE, López-picón F, Knudsen GM, Vercouillie J, Rinne JO, Herholz K, Van Laere K, Santiago-ribeiro MJ, Herth MM, Carroll MA, Bottlaender M, Hansson O, Edison P, Hinz R, Boellaard R, Moresco RM, Pappata S
* Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies (237 visite)
Alzheimers Dement (ISSN: 2352-8729print), 2019 Apr 16; 11: 327-332.
Impact Factor: 14.423
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, Tedeschi G, Montella P, Milan G, Salvatore M, Salvatore E, Baron JC, Pappata S
* Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity (418 visite)
Neuroimage (ISSN: 1053-8119linking), 2018 Aug 1; 176: 246-258.
Impact Factor: 5.835
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore B, D'Amico D, Fonti R
* Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT (245 visite)
Clin Nucl Med (ISSN: 1536-0229electronic, 0363-9762linking), 2018 May; 43(5): 363-364.
Impact Factor: 0.253
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Rosa A, Peluso S, De Lucia N, Russo P, Annarumma I, Esposito M, Manganelli F, Brunetti A, De Michele G, Pappata S
* Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease (345 visite)
Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2018 Feb; 47: 80-83.
Impact Factor: 4.721
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zampella E, Acampa W, Assante R, Nappi C, Gaudieri V, Mainolfi CG, Green R, Cantoni V, Panico M, Klain M, Petretta M, Slomka PJ, Cuocolo A
* Combined evaluation of regional coronary artery calcium and myocardial perfusion by (82)Rb PET/CT in the identification of obstructive coronary artery disease (286 visite)
Eur J Nucl Med (ISSN: 1619-7089electronic, 1619-7070linking, 1619-7070print), 2018 Jan 25; 45(4): 521-529.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cantoni V, Sollini M, Green R, Berchiolli R, Lazzeri E, Mannarino T, Acampa W, Erba PA
* Comprehensive meta-analysis on [18F] FDG PET/CT and radiolabelled leukocyte SPECT–SPECT/CT imaging in infectious endocarditis and cardiovascular implantable electronic device infections (174 visite)
Clin Transl Imaging (ISSN: 2281-5872, 2281-5872print, 2281-7565online), 2018; 6(1): 3-18.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bonaccorso C, Grasso G, Musso N, Barresi V, Condorelli DF, La Mendola D, Rizzarelli E
* Water soluble glucose derivative of thiocarbohydrazone acts as ionophore with cytotoxic effects on tumor cells (224 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 1873-3344electronic), 2018; 182: 92-102.
Impact Factor: 3.317
Dettagli    Esporta in BibTeX    Esporta in EndNote

Greco A, Auletta L, Orlandella FM, Iervolino PLC, Klain M, Salvatore G, Mancini M
* Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer (764 visite) (PDF 162 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2017 Dec 16; 18(12): 1-18.
Impact Factor: 3.687
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
* Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience (354 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Impact Factor: 3.179
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore B, Klain M, Nicolai E, D'Amico D, De Matteis G, Raddi M, Fonti R, Pellegrino T, Storto G, Cuocolo A, Pace L
* Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy (379 visite) (PDF 141 visite)
Medicine (ISSN: 0025-7974), 2017 Oct; 96(42): e8344-e8344.
Impact Factor: 2.028
Dettagli    Esporta in BibTeX    Esporta in EndNote

Longo DL, Stefania R, Aime S, Oraevsky A
* Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications (253 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2017 Aug 7; 18(8): N/D-N/D.
Impact Factor: 3.687
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G
* F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer (361 visite) (PDF 6 visite)
Eur J Radiol (ISSN: 0720-048x), 2017 Aug; 93: 107-113.
Impact Factor: 2.843
Dettagli    Esporta in BibTeX    Esporta in EndNote

Peluso S, Bilo L, Esposito M, Antenora A, De Rosa A, Pappata S, De Michele G
* Chorea-acanthocytosis without chorea: Expanding the clinical phenotype (204 visite)
Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1353-8020print), 2017 May 17; 41: 124-126.
Impact Factor: 4.721
Dettagli    Esporta in BibTeX    Esporta in EndNote

Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S
* Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors (215 visite)
Cancer Imaging (ISSN: 1470-7330, 1470-7330electronic), 2017 Mar 7; 17(1): 10-10.
Impact Factor: 3.016
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gargiulo S, Coda AR, Panico M, Gramanzini M, Moresco RM, Chalon S, Pappata S
* Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography (290 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1827-1936), 2017 Mar; 61(1): 60-75.
Impact Factor: 2.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

Assante R, Zampella E, Arumugam P, Acampa W, Imbriaco M, Tout D, Petretta M, Tonge C, Cuocolo A
* Quantitative relationship between coronary artery calcium and myocardial blood flow by hybrid rubidium-82 PET/CT imaging in patients with suspected coronary artery disease (301 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2017; 24(2): 494-501.
Impact Factor: 4.011
Dettagli    Esporta in BibTeX    Esporta in EndNote

Green R, Cantoni V, Nappi C, Gaudieri V, Zampella E, Assante R, Acampa W
* Radionuclide Imaging of Cardiac Device Infection (137 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2017; 10(4): N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Longo DL, Bartoli A, Consolino L, Bardini P, Arena F, Schwaiger M, Aime S
* In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging (229 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 0008-5472linking), 2016 Nov 15; 76(22): 6463-6470.
Impact Factor: 9.122
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lastoria S, Marciello F, Faggiano A, Aloj L, Caraco C, Aurilio M, D'Ambrosio L, Di Gennaro F, Ramundo V, Camera L, De LucaL, Fonti R, Napolitano V, Colao A
* Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) (225 visite)
Endocrine (ISSN: 1355-008x), 2016 Jun; 52(3): 488-494.
Impact Factor: 3.131
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Salvatore B, De Renzo A, Nicolai E, Del Vecchio S
* Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma (272 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2016 Feb; 41(2): 169-172.
Impact Factor: 4.563
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gargiulo S, Anzilotti S, Coda AR, Gramanzini M, Greco A, Panico M, Vinciguerra A, Zannetti A, Vicidomini C, Dolle F, Pignataro G, Quarantelli M, Annunziato L, Brunetti A, Salvatore M, Pappata S
* Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT (731 visite) (PDF 290 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2016 Jan 27; 43(7): 1348-1359.
Impact Factor: 7.277
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Luca S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (302 visite)
Ann Nucl Med (ISSN: 0914-7187, 1864-6433, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varrone A, Pappata S, Quarantelli M
* Movement disorders: Focus on Parkinson’s disease and related disorders (264 visite)
Pet Ct And Pet Mri In Neurology (ISSN: 9783-3193161479783319316123), 2016; N/D: 103-125.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C, Gaudieri V, Petretta M, Cuocolo A
* Noninvasive Cardiac Imaging in Obesity: Challenges and Opportunities (150 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2016; 9(9): N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maddalena F, Lettini G, Gallicchio R, Sisinni L, Simeon V, Nardelli A, Venetucci AA, Storto G, Landriscina M
* Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography (352 visite)
Mol Imaging (ISSN: 1535-3508), 2015 Sep 1; 14: 490-498.
Impact Factor: 2.216
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, Pane F, Salvatore M, Del Vecchio S
* 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study (399 visite) (PDF 232 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Apr; 40(4): 303-308.
Impact Factor: 4.278
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vicidomini C, Panico M, Greco A, Gargiulo S, Coda ARD, Zannetti A, Gramanzini M, Roviello GN, Quarantelli M, Alfano B, Tavitian B, Dolle F, Salvatore M, Brunetti A, Pappata S
* In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET (620 visite) (PDF 250 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 2015 Mar; 42(3): 309-316.
Impact Factor: 2.429
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C, Acampa W, Pellegrino T, Petretta M, Cuocolo A
* Beyond ultrasound: advances in multimodality cardiac imaging (250 visite)
Intern Emerg Med (ISSN: 1828-0447), 2015 Feb; 10(1): 9-20.
Impact Factor: 2.34
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (363 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (236 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
Dettagli    Esporta in BibTeX    Esporta in EndNote

Romeo V, Esposito A, Maurea S, Camera L, Mainenti PP, Palmieri G, Buonerba C, Salvatore M
* Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison (347 visite)
Pol J Radiol (ISSN: 0137-7183, 1733-134x, 1733-134xlinking), 2015 Jan 13; 80(1): 22-26.
Impact Factor: 0.567
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C, Altiero M, Imbriaco M, Nicolai E, Giudice CA, Aiello M, Diomiaiuti CT, Pisani A, Spinelli L, Cuocolo A
* First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease (382 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42(7): 1025-1031.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

Insabato L, Natella V, Somma A, Persico M, Camera L, Losito NS, Masone S
* Primary Peritoneal Clear Cell Carcinoma Versus Ovarian Carcinoma Versus Malignant Transformation of Endometriosis: A Vexing Issue (275 visite)
Int J Surg Pathol (ISSN: 1066-8969), 2015; 23(3): 211-216.
Impact Factor: 0.782
Dettagli    Esporta in BibTeX    Esporta in EndNote

Formicola F, Riccardi A, Vigliar E, Biondi B, Accurso A, Del Vecchio W, Imbriaco M
* Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings (241 visite)
Breast J (ISSN: 1075-122x), 2014 Nov; 20(6): 653-654.
Impact Factor: 1.411
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (434 visite)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S
* Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography (479 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2014 Sep 15; 20(18): 4806-4815.
Impact Factor: 8.722
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gargiulo S, Petretta MP, Greco A, Panico M, Larobina M, Gramanzini M, Schiattarella GG, Esposito G, Petretta M, Brunetti A, Cuocolo A
* Genetic deletion in uncoupling protein 3 augments 18F-fluorodeoxyglucose cardiac uptake in the ischemic heart (389 visite)
Bmc Cardiovasc Disor (ISSN: 1471-2261), 2014 Sep 8; 14(1): 98-98.
Impact Factor: 1.878
Dettagli    Esporta in BibTeX    Esporta in EndNote

Olgiati S, De Rosa A, Quadri M, Criscuolo C, Breedveld GJ, Picillo M, Pappata S, Quarantelli M, Barone P, De Michele G, Bonifati V
* Park20 Caused By Synj1 Homozygous Arg258gln Mutation In A New Italian Family (444 visite)
Neurogenetics (ISSN: 1364-6745, 1364-6753), 2014 Aug; 15(3): 183-188.
Impact Factor: 2.884
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Alterio C, Avallone A, Tatangelo F, Delrio P, Pecori B, Cella L, Pelella A, D'Armiento FP, Carlomagno C, Bianco F, Silvestro L, Pacelli R, Napolitano M, Iaffaioli RV, Scala S
* A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients (359 visite)
Int J Cancer (ISSN: 0020-7136), 2014 Jul 15; 135(2): 379-390.
Impact Factor: 5.085
Dettagli    Esporta in BibTeX    Esporta in EndNote

Orditura M, Galizia G, Di Martino N, Ancona E, Castoro C, Pacelli R, Morgillo F, Rossetti S, Gambardella V, Farella A, Laterza MM, Ruol A, Fabozzi A, Napolitano V, Iovino F, Lieto E, Fei L, Conzo G, Ciardiello F, De Vita F
* Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study (1837 visite)
Curr Oncol (ISSN: 1198-0052, 1718-7729electronic, 1198-0052linking), 2014 Jun; 21(3): 125-133.
Impact Factor: 1.785
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (424 visite)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A
* Nuclear Cardiology in Heart Failure (333 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2014 Jan; 7(3): 1-7.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Testi S, Peluso S, Fabrizi GM, Antenora A, Russo CV, Pappata S, Padovani A, Ferrarini M, Filla A
* A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia (263 visite)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2014; 41(3): 709-714.
Impact Factor: 4.151
Dettagli    Esporta in BibTeX    Esporta in EndNote

Molino I, Cavaliere C, Salvatore E, Quarantelli M, Colucci L, Fasanaro AM
* Is anterior communicating artery syndrome related to fornix lesions? (255 visite)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2014; 42Suppl3: S199-S199.
Impact Factor: 4.151
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dubbioso R, Pappata S, Quarantelli M, D'Arco F, Manganelli F, Esposito M, Santoro L
* Atypical Clinical And Radiological Presentation Of Cryptococcal Choroid Plexitis In An Immunocompetent Woman (340 visite)
J Neurol Sci (ISSN: 1878-5883, 0022-510x), 2013 Nov; 334(1-2): 180-182.
Impact Factor: 1.453
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, Molinari L, Mainenti P, Cammarota A, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (267 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Impact Factor: 2.415
Dettagli    Esporta in BibTeX    Esporta in EndNote

Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (492 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrino C, Schiattarella GG, Sannino A, Pironti G, Petretta MP, Cannavo A, Gargiulo G, Ilardi F, Magliulo F, Franzone A, Carotenuto G, Serino F, Altobelli GG, Cimini V, Cuocolo A, Lombardi A, Goglia F, Indolfi C, Trimarco B, Esposito G
* Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure (391 visite)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2013 May 20; 2(3): e000086-e000086.
Impact Factor: 2.882
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (401 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pasanisi F, Pace L, Fonti R, Marra M, Sgambati D, De Caprio C, De Filippo E, Vaccaro A, Salvatore M, Contaldo F
* Evidence of brown fat activity in constitutional leanness (450 visite)
J Clin Endocrinol Metab (ISSN: 1945-7197, 0021-972x, 0021-972xlinking), 2013 Mar; 98(3): 1214-1218.
Impact Factor: 6.31
Dettagli    Esporta in BibTeX    Esporta in EndNote

Greco A, Fiumara G, Gargiulo S, Gramanzini M, Brunetti A, Cuocolo A
* High-resolution positron emission tomography/computed tomography imaging of the mouse heart (427 visite)
Exp Physiol Experimental Physiology (ISSN: 1469-445x, 0958-0670), 2013 Mar; 98(3): 645-651.
Impact Factor: 2.871
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S
* Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors (329 visite)
Clin Nucl Med (ISSN: 1536-0229, 0363-3976, 0363-9762), 2013; 38(5): 354-358.
Impact Factor: 2.857
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Larobina M, Del Vecchio S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L
* Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma (457 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pascual B, Prieto E, Arbizu J, Marti-climent JM, Penuelas I, Quincoces G, Zarauza R, Pappata S, Masdeu JC
* Decreased carbon-11-flumazenil binding in early Alzheimer's disease (358 visite) (PDF 248 visite)
Brain (ISSN: 0006-8950, 1460-2156electronic, 0006-8950linking), 2012 Sep; 135(Pt9): 2817-2825.
Impact Factor: 9.915
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, Nevolo MT, Fedele M, Greco A, Greco M, Brunetti G, Fusco A, Foti D, Brunetti A
* The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake (597 visite)
Molecular Endocrinology (ISSN: 0888-8809, 1944-9917electronic), 2012 Sep; 26(9): 1578-1589.
Impact Factor: 4.746
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Iodice D, Cozzolino I, Segreto S, Capece S, Sica G, Magliulo M, Ciancia G, Pace L, Salvatore M
* Tomographic imaging of the spleen: the role of morphological and metabolic features in differentiating benign from malignant diseases (274 visite)
Clin Imaging (ISSN: 1873-4499, 0899-7071, 0899-7071linking), 2012 Sep; 36(5): 559-567.
Impact Factor: 0.648
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sasaki T, Ito H, Kimura Y, Arakawa R, Takano H, Seki C, Kodaka F, Fujie S, Takahata K, Nogami T, Suzuki M, Fujiwara H, Takahashi H, Nakao R, Fukumura T, Varrone A, Halldin C, Nishikawa T, Suhara T
* Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I (391 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Jul; 53(7): 1065-1073.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Greco A, Petretta MP, Larobina M, Gargiulo S, Panico M, Nekolla SG, Esposito G, Petretta M, Brunetti A, Cuocolo A
* Reproducibility and accuracy of non-invasive measurement of infarct size in mice with high-resolution PET/CT (367 visite)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2012 Jun; 19(3): 492-499.
Impact Factor: 2.847
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pier PM
* RE: Imaging Features of Hepato-Splenic Amyloidosis at PET/CT (278 visite)
Korean Journal Of Radiology (ISSN: 1229-6929), 2012 May; 13(3): 368-369.
Impact Factor: 1.555
Dettagli    Esporta in BibTeX    Esporta in EndNote

Orditura M, Galizia G, Morgillo F, Martinelli E, Lieto E, Vitiello F, Di Martino N, Pacelli R, Renda A, Ciardiello F, De Vita F
* Complete Response To Preoperative Chemoradiation And Survival In Esophageal Cancer: A Pooled Analysis Of Three Single-Institution Phase Ii Trials (373 visite)
Diseases Of The Esophagus, 2012 Feb; 142(5): 130-136.
Impact Factor: 2.057
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gargiulo S, Greco A, Gramanzini M, Petretta MP, Ferro A, Larobina M, Panico M, Brunetti A, Cuocolo A
* PET/CT imaging in mouse models of myocardial ischemia (597 visite)
J Biomed Biotechnol (ISSN: 1110-7251, 1110-7243), 2012; 2012: 541872-541872.
Impact Factor: 2.88
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Zampella E, Assante R, Petretta MP, Cuocolo R, Fabiani I, Della Rattal GL, Perrone-Filardi P, Cuocolo A
* Imaging techniques for assessment of coronary flow reserve (362 visite)
Monaldi Arch Chest Dis Card Ser (ISSN: 1122-0643, 1122-0643print), 2011 Dec; 76(4): 192-197.
Impact Factor: 7.132
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fragassi NA, Chiacchio L, Errichiello L, Pappata S, Tedeschi MR, Striano P, Striano S
* Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome (386 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Dec; 32(6): 1129-1133.
Impact Factor: 1.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pappata S, Santangelo G, Aarsland D, Vicidomini C, Longo K, Bronnick K, Amboni M, Erro R, Vitale C, Caprio MG, Pellecchia MT, Brunetti A, De Michele G, Salvatore M, Barone P
* Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism (420 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2011 Oct 4; 77(14): 1357-1362.
Impact Factor: 8.312
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Nicolai E, D'Amico D, Ibello F, Della Morte AM, Salvatore B, Pizzuti LM, Salvatore M, Soricelli A
* Determinants of physiologic 18F-FDG uptake in brown adipose tissue in sequential PET/CT examinations (410 visite)
Molecular Imaging And Biology (ISSN: 1860-2002, 1536-1632), 2011 Oct; 13(5): 1029-1035.
Impact Factor: 3.844
Dettagli    Esporta in BibTeX    Esporta in EndNote

Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, Tedroff J
* Extrastriatal dopamine D 2 receptor binding in Huntington's disease (412 visite)
Hum Brain Mapp (ISSN: 1065-9471, 1097-0193electronic, 1065-9471linking), 2011 Oct; 32(10): 1626-1636.
Impact Factor: 5.88
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varrone A, Stepanov V, Nakao R, Toth M, Gulyas B, Emond P, Deloye JB, Vercouillie J, Stabin MG, Jonsson C, Guilloteau D, Halldin C
* Imaging of the striatal and extrastriatal dopamine transporter with 18F-LBT-999: Quantification, biodistribution, and radiation dosimetry in nonhuman primates (476 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2011 Sep 1; 52(8): 1313-1321.
Impact Factor: 6.381
Dettagli    Esporta in BibTeX    Esporta in EndNote

Erro R, Amboni M, Vitale C, Longo K, Rocco M, Russo C, Pappata S, Brunetti A, Barone P
* The "eye of the tiger" sign in pure akinesia with gait freezing (283 visite) (PDF 209 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Sep; 32(4): 703-705.
Impact Factor: 1.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (541 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A
Current research in nuclear medicine and molecular imaging in Italy: Highlights of the 10th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging (405 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2011 Jun; 55(3): 280-300.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Striano P, Caranci F, Pappata S, Zara F, Striano S
* Hemidystonia in uncontrolled type 2 diabetes mellitus (250 visite)
Arch Neurol (ISSN: 1538-3687electronic, 0003-9942linking), 2011 May; 68(5): 674-675.
Impact Factor: 7.584
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (507 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli    Esporta in BibTeX    Esporta in EndNote

Esmaeilzadeh M, Kullingsjo J, Ullman H, Varrone A, Tedroff J
* Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with huntington disease (330 visite)
Clin Neuropharmacol (ISSN: 0362-5664), 2011 May; 34(3): 95-100.
Impact Factor: 2.166
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L
* Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? (303 visite)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2011 Mar 21; 17(11): 1427-1433.
Impact Factor: 2.471
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varnäs K, Nyberg S, Halldin C, Varrone A, Takano A, Karlsson P, Andersson J, McCarthy D, Smith M, Pierson ME, Söderström J, Farde L
* Quantitative analysis of [11C]AZ10419369 binding to 5-HT 1B receptors in human brain (382 visite)
J Cereb Blood Flow Metab (ISSN: 0271-678x), 2011 Jan; 31(1): 113-123.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, Di Giorgio E, De Renzo A, Pizzuti LM, Cerciello G, Nardelli A, Capacchione D, Castaldi E, Ortosecco G, Pace L
* Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma (456 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2010 Oct; 151(2): 195-197.
Impact Factor: 4.942
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (378 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
Dettagli    Esporta in BibTeX    Esporta in EndNote

Orditura M, Galizia G, Napolitano V, Martinelli E, Pacelli R, Lieto E, Aurilio G, Vecchione L, Morgillo F, Catalano G, Ciardiello F, Del Genio A, Di Martino N, De Vita F
* Weekly Chemotherapy with Cisplatin and Paclitaxel and Concurrent Radiation Therapy as Preoperative Treatment in Locally Advanced Esophageal Cancer: A Phase II Study (311 visite)
Cancer Investigation (ISSN: 0735-7907), 2010 Oct; 28(8): 820-827.
Impact Factor: 2.39
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varrone A, Halldin C
Molecular imaging of the dopamine transporter (505 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore E, Di Maio L, Filla A, Ferrara AM, Rinaldi C, Sacca F, Peluso S, Macchia PE, Pappata S, De Michele G
* Benign hereditary chorea: Clinical and neuroimaging features in an Italian family (328 visite)
Mov Disord (ISSN: 0885-3185, 1531-8257, 0885-3185linking), 2010 Jul 30; 25(10): 1491-1496.
Impact Factor: 4.48
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (539 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli    Esporta in BibTeX    Esporta in EndNote

Finnema SJ, Varrone A, Hwang TJ, Gulyas B, Pierson ME, Halldin C, Farde L
* Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain (318 visite)
Synapse (ISSN: 0887-4476), 2010 Jul; 64(7): 573-577.
Impact Factor: 2.925
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
* PET/CT in cancer research: From preclinical to clinical applications (578 visite)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.
Impact Factor: 4.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
* Molecular imaging of tumor microenvironment (429 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
* Molecular imaging of tumor microenvironment: Challenges and perspectives (560 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cervenka S, Varrone A, Fransen E, Halldin C, Farde L
* PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans (496 visite)
Synapse (ISSN: 0887-4476), 2010 Jun; 64(6): 478-485.
Impact Factor: 2.925
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Segreto S, Mancini M, Rispo A, Cozzolino I, Masone S, Rinaldi CR, Nardone G, Salvatore M
* Intestinal amyloidosis: two cases with different patterns of clinical and imaging presentation (371 visite)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2010 May 28; 16(20): 2566-2570.
Impact Factor: 2.24
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Petretta M, Acampa W, De Falco T
* Gated SPECT myocardial perfusion imaging: The further improvements of an excellent tool (329 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Apr; 54(2): 129-144.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bilo L, Meo R, de Leva MF, Vicidomini C, Salvatore M, Pappata S
* Thalamic activation and cortical deactivation during typical absence status monitored using [18F]FDG-PET: a case report (460 visite)
Seizure (ISSN: 1532-2688, 1059-1311), 2010 Apr; 19(3): 198-201.
Impact Factor: 1.649
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G
* Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation (553 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806.
Impact Factor: 8.017
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, Avitabile G, Pace L, Forestieri P, Salvatore M
* Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions (394 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2010 Mar; 115(2): 215-224.
Impact Factor: 1.618
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (374 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Breatnach E
* Multimodality imaging in Europe: a survey by the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) (399 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2010 Jan; 37(1): 163-167.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (550 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lucignani G, Cuocolo A
Recent advances in the assessment of myocardial viability (336 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2009 Nov; 36(11): 1892-1895.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L
* Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT (348 visite) (PDF 248 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Oct; 36(10): 1639-1650.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lucignani G, Cuocolo A
Advances in quantitative assessment of myocardial blood flow and coronary reserve (214 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2009 Oct; 36(10): 1687-1692.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D, Gulyas B, Halldin C
* In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand (432 visite)
Synapse (ISSN: 0887-4476), 2009 Oct; 63(10): 871-880.
Impact Factor: 2.557
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (799 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli    Esporta in BibTeX    Esporta in EndNote

Takano A, Gulyas B, Varrone A, Maguire RP, Halldin C
* Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: A rhesus monkey study with (S, S)-[18F]FMeNER-D (347 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36(8): 1308-1314.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Criscuolo C, Filla A, Coppola G, Rinaldi C, Carbone R, Pinto S, Wang Q, De Leva MF, Salvatore E, Banfi S, Brunetti A, Quarantelli M, Geschwind DH, Pappata S, De Michele G
* Two novel CYP7B1 mutations in Italian families with SPG5: A clinical and genetic study (323 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2009 Sep; 256(8): 1252-1257.
Impact Factor: 2.903
Dettagli    Esporta in BibTeX    Esporta in EndNote

Imbriaco M, Pisani A, Spinelli L, Cuocolo A, Messalli G, Capuano E, Marmo M, Liuzzi R, Visciano B, Cianciaruso B, Salvatore M
* Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study (323 visite)
Heart (ISSN: 1355-6037, 1468-201x), 2009 Jul; 95(13): 1103-1107.
Impact Factor: 5.385
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alfano B, Larobina M, Salvatore M
* Technological platforms for molecular imaging: A vision of the future (394 visite) (PDF 205 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 67-75.
Impact Factor: 0.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carlomagno C, Farella A, Bucci L, D'Armiento FP, Pesce G, Pepe S, Cannella L, Pacelli R, De Stefano A, Solla R, D'Armiento MR, De Placido S
* Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: A phase II study (697 visite)
Annals Of Oncology (ISSN: 0923-7534), 2009 May; 20(5): 906-912.
Impact Factor: 5.647
Dettagli    Esporta in BibTeX    Esporta in EndNote

Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, Farde L
* [18F]Flumazenil binding to central benzodiazepine receptor studies by PET. - Quantitative analysis and comparisons with [11C]flumazenil (285 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2009 Apr 15; 45(3): 891-902.
Impact Factor: 5.739
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Rosa A, Criscuolo C, Mancini P, De Martino M, Giordano IA, Pappata S, Filla A, De Michele G
* Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy (227 visite)
Parkinsonism Relat D (ISSN: 1353-8020print, 1353-8020linking, 1873-5126electronic), 2009 Mar; 15(3): 242-244.
Impact Factor: 2.406
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (321 visite)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Luca S, Del Gatto A, Ruvo M, Panico M, Zannetti A, Del Vecchio S, Salvatore M, Pedone C, Saviano M, Zaccaro L
* A new and selective radiolabeled alpha(V)beta(3) peptide antagonist as tracer in tumor diagnosis (406 visite)
Adv Exp Med Biol (ISSN: 0065-2598, 0065-2598print), 2009; 611: 439-440.
Impact Factor: 2.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lucignani G, Salvatore M
* Biotechnology in molecular and cellular imaging (246 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009; 21(1): 1-3.
Impact Factor: 0.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (309 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Slomka PJ, Le Meunier L, Hayes SW, Acampa W, Oba M, Haemer GG, Berman DS, Germano G
* Comparison of Myocardial Perfusion (82)Rb PET Performed with CT- and Transmission CT-Based Attenuation Correction (237 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2008 Dec; 49(12): 1992-1998.
Impact Factor: 6.662
Dettagli    Esporta in BibTeX    Esporta in EndNote

Imbriaco M, Caprio MG, Limite G, Pace L, De Falco T, Capuano E, Salvatore M
* Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions (241 visite)
Ajr Am J Roentgenol (ISSN: 1546-3141, 0361-803x, 1546-3141electronic), 2008 Nov; 191(5): 1323-1330.
Impact Factor: 2.94
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Costanzo P, Acampa W, Imbriaco M, Ferro A, Filardi PP, Cuocolo A
* Noninvasive assessment of coronary anatomy and myocardial perfusion: Going toward an integrated imaging approach (275 visite)
J Cardiovasc Med (ISSN: 1558-2027, 1558-2035), 2008 Oct; 9(10): 977-986.
Impact Factor: 1.407
Dettagli    Esporta in BibTeX    Esporta in EndNote

Takano A, Varrone A, Gulyas B, Karlsson P, Tauscher J, Halldin C
* Mapping of the norepinephrine transporter in man using PET with (S, S)-[F-18]FMeNER-D-2 (270 visite) (PDF 200 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2008 Sep 15; 41: 474-482.
Impact Factor: 5.694
Dettagli    Esporta in BibTeX    Esporta in EndNote

Brunetti A, Cuocolo A
* European Science Foundation calls for more and better medical imaging research (209 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Sep; 35(9): 1749-1757.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
* Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type (483 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2008 Aug 15; 14(16): 5209-5219.
Impact Factor: 6.488
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Soricelli A, Storto G, Cuocolo A
* Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers (331 visite)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2008 May; 15(3): 456-465.
Impact Factor: 2.442
Dettagli    Esporta in BibTeX    Esporta in EndNote

Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, Edenbrandt L, Flotats A, Germano G, Stopar TG, Franken P, Kelion A, Kjaer A, Le Guludec D, Ljungberg M, Maenhout AF, Marcassa C, Marving J, Mckiddie F, Schaefer WM, Stegger L, Underw
* EANM/ESC guidelines for radionuclide imaging of cardiac function (501 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Apr; 35(4): 851-885.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pappata S, Salvatore E, Postiglione A
* In vivo imaging of neurotransmission and brain receptors in dementia (337 visite) (PDF 248 visite)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Impact Factor: 1.811
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (331 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caleo O, Maurea S, Klain M, Salvatore B, Storto G, Mancini M, Pace L, Salvatore M
* Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose (258 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2008 Mar; 113(2): 278-288.
Impact Factor: 0.955
Dettagli    Esporta in BibTeX    Esporta in EndNote

Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, Halldin C, Nordstrom AL
* Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET (441 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2008 Feb 1; 39(3): 1408-1419.
Impact Factor: 5.694
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M
* F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma (487 visite)
J Nucl Med (ISSN: 0161-5505, 0161-1550, 1535-5667), 2008 Feb; 49(2): 195-200.
Impact Factor: 6.662
Dettagli    Esporta in BibTeX    Esporta in EndNote

Takano A, Gulyas B, Varrone A, Karlsson P, Schou M, Airaksinen AJ, Vandenhende F, Tauscher J, Halldin C
* Imaging the norepinephrine transporter with positron emission tomography: Initial human studies with (S, S)-[18F]FMeNER-D2 (288 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Jan; 35(1): 153-157.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

Postiglione A, Milan G, Pappata S, De Falco C, Lamenza F, Schiattarella V, Gallotta G, Sorrentino P, Striano S
* Fronto-temporal dementia presenting as Geschwind's syndrome (324 visite)
Neurocase (ISSN: 1355-4794, 1465-3656), 2008; 14(3): 264-270.
Impact Factor: 0.918
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Leva MF, Varrone A, Filla A, Quarantelli M, Bilo L, Piscitelli V, Salvatore E, Ammendola S, Striano S, De Michele G, Bonavita V, Pappata S
* Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias (300 visite)
Mov Disord (ISSN: 0885-3185, 1531-8257, 0885-3185linking), 2007 Oct 31; 22(14): 2117-2121.
Impact Factor: 3.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (349 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
Dettagli    Esporta in BibTeX    Esporta in EndNote

Adam A, Cuocolo A
The "White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging": a message from the ESR and EANM Presidents (315 visite)
Eur Radiol (ISSN: 0938-7994, 1432-1084electronic, 0938-7994linking), 2007 Sep; 17(8): 1924-1925.
Impact Factor: 3.405
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bischof Delaloye A, Carrio I, Cuocolo A, Knapp W, Gourtsoyiannis N, Mccall I, Reiser M, Silberman B
* White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging (272 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Sep; 34(8): 1147-1151.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (570 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
* Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis (366 visite)
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.
Impact Factor: 2.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gustavsson T, Sarkar N, Banyasz A, Markovitsi D, Improta R
* Solvent effects on the steady-state absorption and fluorescence spectra of uracil, thymine and 5-fluorouracil (320 visite)
Photochem Photobiol (ISSN: 0031-8655), 2007 May; 83(3): 595-599.
Impact Factor: 2.172
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorrentino AR, Acampa W, Petretta M, Mainolfi C, Salvatore M, Cuocolo A
* Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction (321 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Apr; 34(4): 558-562.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Copani A, Caraci F, Hoozemans J, Calafiore M, Sortino M, Nicoletti F
* The nature of the cell cycle in neurons: Focus on a "non-canonical" pathway of DNA replication causally related to death (429 visite)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2007 Apr; 1772(4): 409-412.
Impact Factor: 3.078
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (339 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro F, Barone V, Gustavsson T, Improta R
* Solvent effect on the singlet excited-state lifetimes of nucleic acid bases: A computational study of 5-fluorouracil and uracil in acetonitrile and water (260 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2006 Dec 20; 128(50): 16312-16322.
Impact Factor: 7.696
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, Varrone A, Tatsch K
* EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues (460 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Nov; 33(11): 1374-1380.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Seneca N, Gulyas B, Varrone A, Schou M, Airaksinen A, Tauscher J, Vandenhende F, Kielbasa W, Farde L, Innis R, Halldin C
* Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: A PET study in nonhuman primate brain using (S, S)-[18F] FMeNER-D2 (397 visite)
Psychopharmacology (ISSN: 0033-3158), 2006 Sep; 188(1): 119-127.
Impact Factor: 3.625
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Mainolfi C, Ferro A, Ricci F, Evangelista L, Petretta MP, Salvatore M, Cuocolo A
* Comparison of prognostic value of Tc-99m tetrofosmin single-photon emission computed tomography after nitrate administration-vs-metabolic imaging by positron emission tomography in patients with ischemic left ventricular dysfunction (194 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gustavsson T, Sarkar N, Lazzarotto E, Markovitsi D, Barone V, Improta R
* Solvent effect on the singlet excited-state dynamics of 5-fluorouracil in acetonitrile as compared with water (298 visite)
J Phys Chem B (ISSN: 1520-6106, 1520-5207, 1520-5207electronic), 2006 Jul 6; 110(26): 12843-12847.
Impact Factor: 4.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berkouk K, Quarantelli M, Prinster A, Landeau B, Alfano B, Baron JC
* Mapping The Relative Contribution Of Gray Matter Activity Versus Volume In Brain Pet. A New Approach (351 visite) (PDF 216 visite)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2006 Jul; 16(3): 224-235.
Impact Factor: 1.298
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Renzo A, Perna F, Persico M, Mainolfi C, Pace L
* 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma (216 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2006 Jun; 133(6): 580-580.
Impact Factor: 4.498
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Guerra A, Bartoli A, Belcari N, Herbert D, Motta A, Vaiano A, Di Domenico G, Sabba N, Moretti E, Zavattini G, Lazzarotti M, Sensi L, Larobina M
* Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging (264 visite)
Ieee Transactions On Nuclear Science (ISSN: 0018-9499), 2006 Jun; 53(3): 1078-1083.
Impact Factor: 1.497
Dettagli    Esporta in BibTeX    Esporta in EndNote

Larobina M, Brunetti A, Salvatore M
* Small animal PET: A review of commercially available imaging systems (315 visite) (PDF 222 visite)
Curr Med Imaging Rev (ISSN: 1573-4056, 1573-4056linking), 2006 May; 2(2): 187-192.
Impact Factor: 1.059
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (489 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Salvatore M, Del Vecchio S
* Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma (224 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2006 Mar; 47(3): 555-555.
Impact Factor: 4.986
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gustavsson T, Banyasz A, Lazzarotto E, Markovitsi D, Scalmani G, Frisch MJ, Barone V, Improta R
* Singlet excited-state behavior of uracil and thymine in aqueous solution: A combined experimental and computational study of 11 uracil derivatives (369 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2006 Jan 18; 128(2): 607-619.
Impact Factor: 7.696
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against (251 visite)
Eur J Nucl Med (ISSN: 1619-7070print, 1619-7070linking, 1619-7089electronic), 2005 Jul; 32(7): 832-835.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, Manfioletti G, Barbetti F, Brunetti A, Croce CM, Fusco A, Brunetti A
* Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice (365 visite)
Nat Med (ISSN: 1078-8956, 0034-7264), 2005 Jul; 11(7): 765-773.
Impact Factor: 28.878
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Imbriaco M, De Luca N, Iovino GL, Salvatore M
* The many ways to myocardial perfusion imaging (420 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Mar; 49(1): 4-18.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, Alfano B, Brunetti A, Baron JC, Salvatore M
* Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction (499 visite) (PDF 248 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2004 Feb; 45(2): 192-201.
Impact Factor: 5.362
Dettagli    Esporta in BibTeX    Esporta in EndNote

Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R
* 3. 0 T perfusion MR imaging (603 visite)
Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812.
Impact Factor: 0.023
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M
* Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques (303 visite) (PDF 236 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2004; 48(3): 188-197.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

d'Alesio V, Pacelli R, Durante M, Canale Cama G, Cella L, Gialanella G, Grossi G, Pugliese M, Punzo G, Sardi I, Scampoli P, Solla R, Salvatore M
* Lymph nodes in the irradiated field influence the yield of radiation-induced chromosomal aberrations in lymphocytes from breast cancer patients (296 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2003 Nov 1; 57(3): 732-738.
Impact Factor: 4.285
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Romano L, Contegiacomo A, Romano M, Casella V, Cuccuru A, Insabato L, Salvatore M
* Rare diffuse peritoneal malignant neoplasms: CT findings in two cases (228 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2003 Nov; 28(6): 827-830.
Impact Factor: 0.996
Dettagli    Esporta in BibTeX    Esporta in EndNote

He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, Cuocolo A
* Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: Relation to metabolic imaging by PET (354 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2003 Nov; 10(6): 599-606.
Impact Factor: 1.629
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Evangelista L
* Nuclear medicine and positron emission tomography imaging in cardiology (375 visite)
Nucl Med Rev (ISSN: 1506-9680), 2003; 6(1): 59-63.
Impact Factor: 0.155
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Cuocolo A
* Nuclear medicine procedures in cardiovascular diseases: An evidence based approach (445 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2002 Dec; 46(4): 323-330.
Impact Factor: 1.903
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pappata S, Dehaene S, Poline JB, Gregoire MC, Jobert A, Delforge J, Frouin V, Bottlaender M, Dolle F, Di Giamberardino L, Syrota A
* In Vivo detection of striatal dopamine release during reward: A PET study with [11C]raclopride and a single dynamic scan approach (286 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2002 Sep; 16(4): 1015-1027.
Impact Factor: 5.624
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore M, Fonti R
* New frontiers of nuclear medicine (410 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2002 May; 88(3): S60-S60.
Impact Factor: 0.267
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alfano B, Prinster A, Quarantelli M
* Method For Preparing Digital Image For Realizing Bimorphic Multicompartmental Phantom Used In E. G. Positron Emission Tomography, Involves Verifying Adjacency Of Voxels For Defining Connected Volume Of Tissue (384 visite)
Patent Office, 2002; N/D: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zingone A, Seidel J, Aloj L, Caraco C, Vaquero JJ, Jagoda EM, Chou JY, Green MV, Eckelman WC
* Monitoring the correction of glycogen storage disease type 1a in a mouse model using [18F]FDG and a dedicated animal scanner (229 visite)
Life Sci (ISSN: 0024-3205), 2002; 71(11): 1293-1301.
Impact Factor: 1.824
Dettagli    Esporta in BibTeX    Esporta in EndNote

Danforth Dn JR, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD
* The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer (256 visite)
Breast Cancer Res Tr Kluwer Academic Publishers (ISSN: 0167-6806), 2002; 75(2): 135-146.
Impact Factor: 3.132
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Cuocolo A
* Myocardial viability assessment in regions of left ventricular dysfunction. Part II: The present and future of echocardiography and magnetic resonance imaging (234 visite)
Nuclear Medicine Communications (ISSN: 0143-3636, 1473-5628), 2001 Jul; 22(7): 731-735.
Impact Factor: 1.19
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Cuocolo A
* Myocardial viability assessment in regions of left ventricular dysfunction. Part I: Radionuclide imaging and clinical implications (311 visite)
Nuclear Medicine Communications (ISSN: 0143-3636, 1473-5628), 2001 Jun; 22(6): 607-611.
Impact Factor: 1.19
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W
* Nuclear cardiology in the new millennium (307 visite)
Rev Esp Med Nucl (ISSN: 0212-6982), 2001 Jun; 20(4): 305-308.
Impact Factor: 0.155
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M
* The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses (225 visite) (PDF 236 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2001 Jun; 42(6): 884-892.
Impact Factor: 4.51
Dettagli    Esporta in BibTeX    Esporta in EndNote

Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A
* Absolute quantification by positron emission tomography of the endogenous ligand (274 visite)
J Cereb Blood Flow Metab (ISSN: 0271-678x), 2001 May; 21(5): 613-630.
Impact Factor: 5.477
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Di Benedetto C, Cuocolo A
An overview of radiotracers in nuclear cardiology (333 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2000 Nov; 7(6): 701-707.
Impact Factor: 1.854
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions (287 visite) (PDF 236 visite)
Ajr Am J Roentgenol (ISSN: 0361-803x, 0361-803xlinking), 1999 Jul; 173(1): 25-29.
Impact Factor: 2.307
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Salvatore M
Clinical imaging of multidrug resistance in cancer (345 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.
Impact Factor: 2.125
Dettagli    Esporta in BibTeX    Esporta in EndNote

Quarantelli M, Alfano B, Larobina M, Tedeschi E, Brunetti A, Covelli EM, Ciarmiello A, Mainolfi C, Salvatore M
Frequency encoding for simultaneous display of multimodality images (794 visite) (PDF 184 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1999 Mar; 40(3): 442-447.
Impact Factor: 3.326
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainolfi C, Maurea S, Varrella P, Alaia C, Imparato C, Alfano B, Abate G, Bazzicalupo L
Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment (278 visite)
Radiol Med (ISSN: 1826-6983, 0033-8362, 1826-6983electronic), 1998 Jan; 95(1-2): 98-104.
Impact Factor: 0.967
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainolfi C, Maurea S, Varrella P, Alaia C, Imparato C, Alfano B, Abate G, Bazzicalupo L
18-FDG PET in the staging and follow-up of lymphoma patients: Comparison with clinical and radiologic findings (280 visite)
Radiol Med (ISSN: 1826-6983, 0033-8362, 1826-6983electronic), 1998; 95(1-2): 98-104.
Impact Factor: 0.967
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Mainolfi C, Bazzicalupo L, Panico M, Imparato C, Alfano B, Ziviello M, Salvatore M
Characterization of adrenal tumors using F-18 FDG PET imaging: Comparison between benign and malignant lesions (408 visite) (PDF 236 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 May; 38(5SUPPL.): 25-29.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Wang H, Maurea S, Mainolfi C, Fiore F, Gravina A, Panico M, Bazzicalupo L, Salvatore M
Tc-99m MIBI scintigraphy in patients with lung cancer comparison with CT and fluorine-18 FDG PET imaging (270 visite)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1997 Apr; 22(4): 243-249.
Impact Factor: 0.34
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Mainolfi C, Wang H, Varrella P, Panico M, Klain M, Rossi R, Cremona F, Bazzicalupo L, Salvatore M
Positron Emission Tomography (pet) With Fludeoxyglucose F 18 In The Study Of Adrenal Masses: Comparison Of Benign And Malignant Lesions (251 visite)
Radiol Med, 1996 Dec; 92(6): 782-787.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Brunetti A, Alfano B, Soricelli A, Tedeschi E, Mainolfi C, Covelli EM, Aloj L, Panico M, Bazzicalupo L, Salvatore M
Functional characterization of brain tumors: An overview of the potential clinical value (509 visite) (PDF 231 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 699-715.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Postiglione A, Soricelli A, Covelli EM, Iazzetta N, Ruocco A, Milan G, Santoro L, Alfano B, Brunetti A
Premature aging in Werner's syndrome spares the central nervous system (432 visite) (PDF 201 visite)
Neurobiol Aging (ISSN: 0197-4580, 1558-1497electronic, 0197-4580linking), 1996 May; 17(3): 325-330.
Impact Factor: 2.872
Dettagli    Esporta in BibTeX    Esporta in EndNote

Brunetti A, Soricelli A, Rotondo A, Alfano B, Raman R, Celentano L, Di Chiro G, Salvatore M
Correlative morphologic and functional imaging for diagnosis, staging and follow up in AIDS: an overview (225 visite)
Q J Nucl Med (ISSN: 1125-0135, 0392-2020, 1124-3937), 1995 Sep; 39(3): 201-211.
Impact Factor: 2.125
Dettagli    Esporta in BibTeX    Esporta in EndNote

BRUNETTI A, TEDESCHI G, SORICELLI A, SALVIA S, ALFANO B, COVELLI E, ALOJ L, BONAVITA V, SALVATORE M
MENSTRUAL EPILEPSY - DIAGNOSTIC CHARACTERIZATION BY POSITRON EMISSION TOMOGRAPHY AND QUANTITATIVE EEG (313 visite)
Neuroradiologia 1992 Vol Ii, 1992; N/D: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pozzilli C, Bernardi S, Mansi L, Picozzi P, Iannotti F, Alfano B, Bozzao L, Lenzi GL, Salvatore M, Conforti P
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography (563 visite) (PDF 267 visite)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 1988 Sep; 51(8): 1058-1062.
Impact Factor: 3.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2534 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

191 Records (181 escludendo Abstract e Conferenze).
Impact factor totale: 672.525 (641.168 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 674.385 (639.319 escludendo Abstract e Conferenze).

Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote

Vai a inizio pagina

Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:15:02
345 views visite. Last view on Ultima visita in data Tuesday 16 November 2021, 23:46:43

IBB website - v.1.0.166 - 11/11/2021 - by Marco Comerci. Copyright 2021 © CNR Istituto di Biostrutture e Bioimmagini.